SE416206B - Analogiforfarande for framstellning av aminderivat av vinblastin, leurosidin och leurokristin - Google Patents

Analogiforfarande for framstellning av aminderivat av vinblastin, leurosidin och leurokristin

Info

Publication number
SE416206B
SE416206B SE7404380A SE7404380A SE416206B SE 416206 B SE416206 B SE 416206B SE 7404380 A SE7404380 A SE 7404380A SE 7404380 A SE7404380 A SE 7404380A SE 416206 B SE416206 B SE 416206B
Authority
SE
Sweden
Prior art keywords
leurocristin
leurosidine
vinblastin
preparation
analogy procedure
Prior art date
Application number
SE7404380A
Other languages
English (en)
Swedish (sv)
Inventor
G J Cullinan
K Gerzon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SE416206B publication Critical patent/SE416206B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04Dimeric indole alkaloids, e.g. vincaleucoblastine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7404380A 1973-04-02 1974-04-01 Analogiforfarande for framstellning av aminderivat av vinblastin, leurosidin och leurokristin SE416206B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02

Publications (1)

Publication Number Publication Date
SE416206B true SE416206B (sv) 1980-12-08

Family

ID=23363051

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7404380A SE416206B (sv) 1973-04-02 1974-04-01 Analogiforfarande for framstellning av aminderivat av vinblastin, leurosidin och leurokristin

Country Status (28)

Country Link
JP (2) JPS5919117B2 (xx)
AR (2) AR204004A1 (xx)
AT (1) AT340605B (xx)
BE (1) BE813168A (xx)
BG (3) BG21235A3 (xx)
CA (1) CA1042428A (xx)
CH (1) CH603669A5 (xx)
CS (1) CS185223B2 (xx)
CY (1) CY1044A (xx)
DD (1) DD113538A5 (xx)
DE (1) DE2415980A1 (xx)
DK (1) DK141511B (xx)
ES (2) ES424882A1 (xx)
FR (1) FR2223044B1 (xx)
GB (1) GB1463575A (xx)
HK (1) HK20180A (xx)
HU (1) HU171572B (xx)
IE (1) IE39071B1 (xx)
IL (1) IL44415A (xx)
KE (1) KE3028A (xx)
MY (1) MY8100025A (xx)
NL (1) NL181079C (xx)
PH (1) PH13623A (xx)
RO (2) RO73524B (xx)
SE (1) SE416206B (xx)
SU (4) SU731900A3 (xx)
YU (3) YU39719B (xx)
ZA (1) ZA741674B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (xx) * 1976-09-08 1982-07-07 Lilly Co Eli
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
LU83822A1 (fr) * 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
FR2623504B1 (fr) * 1987-11-25 1990-03-09 Adir Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
WO2006077424A1 (en) 2005-01-21 2006-07-27 Astex Therapeutics Limited Pharmaceutical compounds
SG164368A1 (en) 2005-07-18 2010-09-29 Bipar Sciences Inc Treatment of cancer
WO2008030891A2 (en) 2006-09-05 2008-03-13 Bipar Sciences, Inc. Inhibition of fatty acid synthesis by parp inhibitors and methods of treatment thereof
CA2662517A1 (en) 2006-09-05 2008-03-13 Jerome Moore Treatment of cancer
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
US7732491B2 (en) 2007-11-12 2010-06-08 Bipar Sciences, Inc. Treatment of breast cancer with a PARP inhibitor alone or in combination with anti-tumor agents
AU2014253584B2 (en) * 2013-04-19 2017-02-02 Jinan University Vinca Alkaloid Derivatives, Preparation Method therefor and Application thereof
CN113456797B (zh) * 2021-06-18 2024-03-08 暨南大学 长春碱类衍生物在制备治疗骨肉瘤和/或软组织肉瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Also Published As

Publication number Publication date
HK20180A (en) 1980-04-25
RO73524A (ro) 1984-10-31
ZA741674B (en) 1975-10-29
AT340605B (de) 1977-12-27
IL44415A (en) 1978-08-31
IE39071B1 (en) 1978-08-02
FR2223044B1 (xx) 1978-06-30
ES424882A1 (es) 1976-12-16
YU39876B (en) 1985-04-30
DE2415980A1 (de) 1974-10-10
MY8100025A (en) 1981-12-31
NL181079C (nl) 1987-06-16
DK141511B (da) 1980-04-08
HU171572B (hu) 1978-02-28
CH603669A5 (xx) 1978-08-31
ES446571A1 (es) 1977-06-16
JPS6033837B2 (ja) 1985-08-05
RO77533A (ro) 1982-02-01
FR2223044A1 (xx) 1974-10-25
KE3028A (en) 1980-03-28
NL181079B (nl) 1987-01-16
BG21235A3 (bg) 1976-03-20
AR203882A1 (es) 1975-10-31
BG22831A3 (bg) 1977-04-20
SU623522A3 (ru) 1978-09-05
YU113980A (en) 1982-05-31
YU39719B (en) 1985-04-30
BG21612A3 (bg) 1976-07-20
BE813168A (fr) 1974-10-02
IL44415A0 (en) 1974-06-30
RO73524B (ro) 1984-11-30
SU652896A3 (ru) 1979-03-15
CS185223B2 (en) 1978-09-15
YU81774A (en) 1982-05-31
JPS59193895A (ja) 1984-11-02
GB1463575A (en) 1977-02-02
IE39071L (en) 1974-10-02
DK141511C (xx) 1980-09-29
SU731900A3 (ru) 1980-04-30
DD113538A5 (xx) 1975-06-12
SU784783A3 (ru) 1980-11-30
AR204004A1 (es) 1975-11-12
NL7404423A (xx) 1974-10-04
PH13623A (en) 1980-08-07
YU39875B (en) 1985-04-30
YU113880A (en) 1982-05-31
DE2415980C2 (xx) 1989-11-09
ATA267974A (de) 1977-04-15
CY1044A (en) 1980-08-01
CA1042428A (en) 1978-11-14
JPS49128000A (xx) 1974-12-07
AU6671974A (en) 1975-09-18
JPS5919117B2 (ja) 1984-05-02

Similar Documents

Publication Publication Date Title
SE416206B (sv) Analogiforfarande for framstellning av aminderivat av vinblastin, leurosidin och leurokristin
SE423631B (sv) Forfarande for framstellning av oxaalhyl-dialkylxantiner
SE7606225L (sv) Forfarande for framstellning av heteroarylforeningar
SE422791B (sv) Analogiforfarande for framstellning av n-(metoximetyl-furylmetyl)-6,7-bensomorfaner
SE7710599L (sv) Forfarande for framstellning av bensisoxazoler
SE420604B (sv) Forfarande for framstellning av oxazolderivat
SE420598B (sv) Analogiforfarande for framstellning av naftalenderivat
SE411212B (sv) Forfarande for framstellning av 3-halogen-cefalosporiner
NO143531C (no) Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater.
SE7712151L (sv) Forfarande for framstellning av linkomycinderivat
NO146596C (no) Fremgangsmaate for fremstilling av 6-deoksytetracykliner
SE417601B (sv) Forfarande for framstellning av amidinokarbamider
NO790627L (no) Fremgangsmaate for fremstilling av hydroksyalkylxantiner
SE413404B (sv) Forfarande for framstellning av pyrazolderivat
NO843825L (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin
SE417319B (sv) Analogiforfarande for framstellning av ergopeptiner
SE419543B (sv) Forfarande for framstellning av vissa angivna isokinolinderivat
SE7613500L (sv) Forfarande for framstellning av cefemderivat
SE434953B (sv) Analogiforfarande for framstellning av amidderivat av vinblastin, leurosidin, leurokristin och beslektade dimera alkaloider
SE399557B (sv) Forfarande for framstellning av tiantren-, tioxanten- och fenoxatiinderivat
SE409994B (sv) Forfarande for framstellning av amidinokarbamider
SE411211B (sv) Forfarande for framstellning av 3-halogencefalosporiner
SE415659B (sv) Forfarande for framstellning av basiskt substituerade xanten- och tioxantenderivat
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
AR209281A1 (es) Procedimiento de preparacion de derivados de ciclopropilfenilpirrolidina

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7404380-3

Effective date: 19940510

Format of ref document f/p: F